ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.990
-0.030 (-1.49%)
At close: Aug 13, 2025, 4:00 PM
1.970
-0.020 (-1.01%)
Pre-market: Aug 14, 2025, 9:13 AM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $91.85 million as of August 14, 2025. Its market cap has increased by 310.03% in one year.
Market Cap
91.85M
Enterprise Value
93.83M
1-Year Change
310.03%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $91.85M, a decrease of -63.35%. That is a compound annual growth rate of -19.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 91.80M | 719.64% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 590.49B |
| Johnson & Johnson | 418.57B |
| AbbVie | 355.17B |
| UnitedHealth Group | 244.30B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.97B |
| Novo Nordisk | 223.00B |